PHOENIX, Dec. 19, 2017 (GLOBE NEWSWIRE) — Can a synthetic formulation of cannabidiol (CBD), one of the main molecules in cannabis, safely help control treatment-resistant “staring†… read more at: http://markets.businessinsider.com/news/stocks/INSYS-Therapeutics-Initiates-Phase-2-Clinical-Trial-of-Cannabidiol-CBD-Oral-Solution-for-Treatment-of-Refractory-Childhood-Absence-Epilepsy-in-Pediatric-PatientsProof-of-concept-study-aims-to-1011641158

by

On Thursday GW Pharmaceuticals plc (NASDAQ:GWPH) announced that the recently submitted New Drug Application for Epidiolex was accepted for filing with Priority Review by the U.S. Food and Drug Administration. The drug, a CBD-based treatment, is designed for patients suffering from seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two conditions that stem from childhood […]

by

For a long time, it’s been a “no-no” to discuss, and for some runners it may have even been a closet recreational activity. But as it gains popularity as legalization continues, more and more athletes are opening the discussion of cannabis use and their training. So, let’s just get right to it: More people are […]

by

What happened After the company announced its progress in developing drugs derived from marijuana cannabinoids, shares of Insys Therapeutics (NASDAQ:INSY) shot up 81.5% in December, according to SP Global Market Intelligence. So what Insys Therapeutics would probably like a do-over on the first 11 months of 2017, but shares came roaring back in December after management reported […]

by

Epidiolex, and oral solution of pure plant-derived cannabidiol, or CBD, is GW’s lead candidate in development for severe, orphan, treatment-resistant epilepsy syndromes such as Dravet syndrome and Lennox-Gastaut syndrome (LGS). Last month the London, UK-headquartered firm submitted its New Drug Application (NDA) for Epidiolex to the US Food and Drug Administration (FDA) to review, and […]

by

Der Antrag für Epidiolex stützt sich auf Daten aus drei Phase-III-Studien mit ungefähr 1500 Patienten. Zwei Untersuchungen hatten ihren primären Endpunkt erreicht. Eine allgemein gute Verträglichkeit des Medikaments wurde dokumentiert. Neben Daten zur Sicherheit und Wirksamkeit beinhaltet der Zulassungsantrag präklinische Daten sowie Daten zur Toxikologie und klinischer Pharmakologie. Epidiolex soll als Ergänzungstherapie bei Anfällen in […]

by

Der Antrag für Epidiolex stützt sich auf Daten aus drei Phase-III-Studien mit ungefähr 1500 Patienten. Zwei Untersuchungen hatten ihren primären Endpunkt erreicht. Eine allgemein gute Verträglichkeit des Medikaments wurde dokumentiert. Neben Daten zur Sicherheit und Wirksamkeit beinhaltet der Zulassungsantrag präklinische Daten sowie Daten zur Toxikologie und klinischer Pharmakologie. Epidiolex soll als Ergänzungstherapie bei Anfällen in […]

by

Shutterstock photo (RTTNews.com) – The following are some of today’s top gainers in the pharma/biotech sector. 1. Arrowhead Pharmaceuticals Inc. (ARWR) Gained 24.73% to close Wednesday’s (Jan.3) trading at $4.64. The stock hit a new intraday high of $4.88. News: No news Pipeline: In 2016, Arrowhead had to discontinue development of prior generation drugs, ARC-520, […]

by

Whenever Zachary Smith posts new content, you’ll get an email delivered to your inbox with a link. Email notifications are only sent once a day, and only if there are new matching items. … read more at: http://muscatinejournal.com/muscatine/news/local/county-attorney-issues-reminder-cannabidiol-is-illegal/article_fe0d4479-5195-58d0-a868-a2c914284b75.html

by

The Brazilian government has authorized HempMeds Brasil, a unit of California-based Medical Marijuana, to import the parent company’s hemp cannabidiol (CBD) oil flagship product — known as Real Scientific Hemp Oil (RSHO) — for the management of multiple sclerosis (MS) symptoms. This is the first time Brazil’s National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária, or ANVISA), has […]

by

Oil industry of cannabis is a new indoor growing industry, and it is wholly a new category of products which rises rapidly. Cannabis hemp oil it is also known as CBD oil. The derived amounts of exceedingly obliged hemp, and it is available for online purchasing, and it delivers directly to your door. It also […]

by

Image : geralt A King’s College London clinical trial involving the cannabis compound CBD has shown it may be beneficial in treating psychosis in schizophrenia. While cannabis can pose a risk to people with schizophrenia, this is thought to be primarily due to the effects tetrahydrocannabinol (THC), the psychoactive component that can induce paranoia, anxiety […]

by